Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Novo Nordisk

The Guardian view on anti-obesity drugs: treating a disease that modernity made

Editorial: Weight-loss drugs reveal that obesity is not a deep-seated aspect of character but something more contingent

The Guardian - UK

FDA says watch out for fake Ozempic, a diabetes drug used by many for weight loss

Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns.

WEKU

FDA warns that counterfeit Ozempic is flooding US supply chain

Officials have seized thousands of counterfeit units

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Seizes Thousands of Counterfeit Ozempic Shots for Diabetes

Counterfeit Ozempic diabetes drug seized by FDA, prompting concerns over identity, quality, and safety. Report suspect packages to FDA hotline.

Top News

Dow Jones Futures Fall As Nike Dives; Apple Leads Six Stocks To Watch With Inflation Data Due

The major indexes rebounded Thursday, with the Fed's favorite inflation data due. Apple and Carnival lead stocks to watch.

Investors Business Daily

'I had to set two alarms at night to check my glucose to make sure I wouldn’t die': meet the revolutionary who won't stop until cycling is safer

The UCI banned his technology from races, yet Supersapiens boss Phil Southerland tells Chris Marshall-Bell he is still dead set on changing the sport in the most profound way for decades

Cycling Weekly

Weight loss from Lilly’s Zepbound drug reversed after stopping treatment, according to study

‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly Stock Skids On A Key New Finding For Its Obesity Drug, Zepbound

Eli Lilly stock skidded Monday after a new study showed patients who stopped taking its weight-loss drug slowly regained weight over a year.

Investors Business Daily

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

International Business Times

Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives

Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study.

Investors Business Daily

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

Weight-loss drug Wegovy faces high demand, limited supply, and tricky health care systems to navigate.

Fortune

Dow Jones Futures Fall: Market Rally Looks Great, But Beware This; 8 Stocks Near Buy Points

The market rally continues its strong November run, but a key fear gauge raises some concerns. Weight-loss drug giant Novo Nordisk broke out Friday, leading stocks to watch.

Investors Business Daily

3 Buy-Rated Healthcare Dividend Stocks for Income Investors

Looking for analysts' favorite stock picks in a traditionally defensive sector, with solid dividend payments to help boost your returns? Here's a look at three stocks for income investors to consider at current levels.

Barchart

Eli Lilly Stock Nears Another Record As Drugmaker Enters The Weight-Loss Arena

Eli Lilly stock is Monday's IBD Stock Of The Day. Shares are forming a new flat base after the FDA approved Lilly's new weight-loss drug.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Revealed: obesity jab maker discussed targeting benefit claimants with UK government

Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection

Investors Business Daily

GE, Amazon Lead 5 Stocks Near Buy Points With This Bullish Trait

Relative strength is key when choosing top stocks. GE stock and Amazon stock pass the RS Line Blue Dot screen.

Investors Business Daily

Dow Jones Futures Rise, 3 Big Movers; Elon Musk's 'Actual Truth' Hits Tesla

The S&P 500 edged higher Thursday despite earnings losers. Leading stocks were resilient. Tesla fell after Elon Musk's 'actual truth' post.

Investors Business Daily

Novo Nordisk Eyes Another Breakout As Weight-Loss Battle Continues

Novo Nordisk stock is Thursday's IBD Stock Of The Day after a study showed weight-loss drug, Wegovy, cut down on heart attacks and strokes.

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Germany considers banning Ozempic exports, including to U.S.

Germany exports Ozempic to the EU and the U.S., Karl Broich, president of the German Federal Institute for Drugs and Medical Devices, told Der Spiegel.

Investors Business Daily

Novo Nordisk Stock Skids — But These Weight-Loss Results Are 'Hard To Ignore'

Novo Nordisk stock slumped Monday despite unveiling promising test results for weight-loss drugs and diabetes development.

Fortune

Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports

Wegovy was found to cut the risk of serious heart events by 20%—Novo Nordisk has now asked the U.S. FDA to reflect the heart benefits in the drug's label.

The Independent UK

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients

Fortune

Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug

U.S. regulators signed off on Eli Lilly’s diabetes drug Zepbound, which can also be used to aid weight loss like Wegovy and Ozempic.

The Guardian - UK

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

Newsroom.co.nz

How a 'Rule of Two' could remove our barrier to better drug access

We need to address the unnecessary and wasteful Medsafe approval for tried and tested drugs by much bigger regulatory authorities abroad, argues Dr Eric Crampton

1 … 9 10 11 12

People

Lars Fruergaard Jørgensen

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.